Prematurity Predicts Neurodevelopmental Outcomes in Congenital Heart Disease

Jenna A Katz1,2, Kimberlee Gauvreau2,3,4, Samantha C Butler5,6

  • 1Division of Newborn Medicine Boston Children's Hospital Boston MA USA.

Insights

Prematurity significantly impacts neurodevelopmental outcomes in children with congenital heart disease (CHD). Infants born very preterm (≤33 weeks) showed the poorest cognitive and motor scores, highlighting the need for early interventions.

Area of Science:

  • Pediatric Cardiology
  • Neurodevelopmental Pediatrics
  • Neonatology

Background:

  • Neurodevelopmental impairment is prevalent in both prematurity and congenital heart disease (CHD).
  • Preterm infants with CHD face a compounded risk, exhibiting worse outcomes than those with either condition alone.
  • This vulnerability underscores the need to investigate the specific impact of prematurity on neurodevelopment in infants with CHD.

Purpose of the Study:

  • To assess the impact of gestational age on neurodevelopmental outcomes in infants with CHD.
  • To identify specific gestational age thresholds associated with adverse cognitive, language, and motor development.
  • To inform targeted neurodevelopmental surveillance and intervention strategies for high-risk infants with CHD.

Main Methods:

  • Retrospective cohort study of 1350 infants with CHD undergoing cardiac surgery (2007-2020).
  • Neurodevelopmental outcomes assessed using the Bayley Scales of Infant and Toddler Development, Third Edition.
  • Infants stratified by gestational age; multivariable regression analysis adjusted for covariates.

Main Results:

  • Among 513 infants who completed testing, 13% were preterm.
  • Gestational age independently predicted cognitive and motor scores; infants born ≤33 weeks had significantly lower scores.
  • Lower caregiver education, Black race, longer hospitalization, and genetic diagnosis also predicted poorer outcomes.

Conclusions:

  • Prematurity, particularly extreme prematurity (≤33 weeks), is a significant risk factor for adverse cognitive and motor development in children with CHD.
  • These findings emphasize the critical need for enhanced neurodevelopmental surveillance.
  • Targeted early intervention strategies are crucial for this vulnerable pediatric population.
Abstract